HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF Class U Units (USD)

ETF | Others |

Last Closing

CAD 7.4

Change

+0.13 (+1.79)%

Market Cap

N/A

Volume

8.31K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.01 (+0.04%)

CAD 6.19B
CASH:CA Horizons High Interest Savings..

-0.15 (-0.30%)

CAD 4.83B
PHYS-U:CA Sprott Physical Gold Trust

+0.23 (+1.35%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.07 (+0.11%)

CAD 4.54B
CEF-U:CA Sprott Physical Gold and Silve..

+0.25 (+1.25%)

CAD 3.78B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+0.58 (+1.40%)

CAD 3.75B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

-0.10 (-0.70%)

CAD 2.91B
XEQT:CA iShares Core Equity Portfolio

-0.02 (-0.07%)

CAD 2.86B
NUBF:CA NBI Unconstrained Fixed Income..

-0.01 (-0.05%)

CAD 2.49B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.31% 72% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.31% 70% C- 75% C
Trailing 12 Months  
Capital Gain -5.73% 69% C- 72% C
Dividend Return 2.23% 93% A 74% C
Total Return -3.50% 77% C+ 74% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -2.76% 12% F 22% F
Dividend Return 2.14% 35% F 38% F
Total Return 4.91% 91% A- 86% B+
Risk Return Profile  
Volatility (Standard Deviation) 4.78% 83% B 89% A-
Risk Adjusted Return 44.64% 58% F 61% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.